Summary
Thermo Fisher Scientific Inc. (TMO) filed an 8-K on July 28, 2016, to report its financial results for the fiscal quarter ended July 2, 2016. This filing primarily serves to furnish the accompanying press release, which contains the detailed financial performance data. Investors should refer to Exhibit 99.1, the press release, for specific figures related to revenue, earnings, and other key financial metrics for the quarter. The company is providing this information to the market in accordance with its reporting obligations, enabling shareholders to stay informed about its operational and financial condition. While the 8-K itself is brief and largely procedural, the attached press release is the crucial document for understanding TMO's performance during the reported quarter. It's important to note that the information furnished in this 8-K, including the press release, is not considered "filed" for the purposes of Section 18 of the Exchange Act, meaning it doesn't carry the same legal liabilities. However, it is still a vital source for investors assessing the company's trajectory and for making informed investment decisions.
Key Highlights
- 1Thermo Fisher Scientific (TMO) announced its financial results for the fiscal quarter ended July 2, 2016.
- 2The company filed a Form 8-K on July 28, 2016, to report these results.
- 3The financial results are detailed in a press release attached as Exhibit 99.1 to the 8-K.
- 4Investors are directed to Exhibit 99.1 for comprehensive financial performance data for the quarter.
- 5The information provided is furnished, not filed, under Section 18 of the Exchange Act.
- 6This filing ensures transparency and timely disclosure of TMO's quarterly performance to the market.